Beyond expectations: disease duration and psychological burden in psoriatic arthritis

dc.contributor.author Kilic, Gamze
dc.contributor.author Kilic, Erkan
dc.contributor.author Tekeoglu, Ibrahim
dc.contributor.author Sargin, Betul
dc.contributor.author Cengiz, Gizem
dc.contributor.author Balta, Nihan Cuzdan
dc.contributor.author Nas, Kemal
dc.contributor.other 01. Atılım University
dc.date.accessioned 2024-07-05T15:22:30Z
dc.date.available 2024-07-05T15:22:30Z
dc.date.issued 2023
dc.description Yurdakul, Ozan Volkan/0000-0003-4567-8133; Nas, Kemal/0000-0002-5845-0851; Acer Kasman, Sevtap/0000-0002-4805-0555; Orhan, Kevser/0000-0001-8639-751X; Ecesoy, Hilal/0000-0001-9274-168X; Kilic, Gamze/0000-0003-1998-0988; Mülkoglu, Cevriye/0000-0001-9113-3885; KILIÇ, Erkan/0000-0003-4355-4356; şen, nesrin/0000-0003-0966-0075; Keskin, Yasar/0000-0003-4457-5917; KAMANLI, AYHAN/0000-0001-5299-7250; TEKEOGLU, IBRAHIM/0000-0003-3395-7178; cuzdan balta, nihan/0000-0001-7238-657X; alkan, hakan/0000-0001-8461-9131 en_US
dc.description.abstract This study aims to investigate the relationship between disease duration and psychological burden in PsA and to identify the risk factors associated with psychological distress. Patients with PsA who met CASPAR classification criteria enrolled by Turkish League Against Rheumatism (TLAR)-Network. Patients were categorized into three groups based on disease duration: early stage (< 5 years), middle stage (& GE; 5, < 10 years), and late stage (& GE; 10 years). All patients underwent clinical and laboratory assessment using standardized protocol and case report forms. The associations between psychological variables and clinical parameters were assessed by a multivariate analysis. Of the 1113 patients with PsA (63.9% female), 564 (%50.7) had high risk for depression and 263 (%23.6) for anxiety. The risk of psychological burden was similar across all PsA groups, and patients with a higher risk of depression and anxiety also experienced greater disease activity, poorer quality of life, and physical disability. Multivariate logistic regression revealed that female gender (OR = 1.52), PsAQoL (OR = 1.13), HAQ (OR = 1.99), FiRST score (OR = 1.14), unemployment/retired (OR = 1.48) and PASI head score (OR = 1.41) were factors that influenced the risk of depression, whereas the current or past enthesitis (OR = 1.45), PsAQoL (OR = 1.19), and FiRST score (OR = 1.26) were factors that influenced the risk of anxiety. PsA patients can experience a comparable level of psychological burden throughout the course of their disease. Several socio-demographic and disease-related factors may contribute to mental disorders in PsA. In the present era of personalized treatment for PsA, evaluating psychiatric distress can guide tailored interventions that improve overall well-being and reduce disease burden. en_US
dc.identifier.doi 10.1007/s00296-023-05379-2
dc.identifier.issn 0172-8172
dc.identifier.issn 1437-160X
dc.identifier.scopus 2-s2.0-85164103430
dc.identifier.uri https://doi.org/10.1007/s00296-023-05379-2
dc.identifier.uri https://hdl.handle.net/20.500.14411/2210
dc.language.iso en en_US
dc.publisher Springer Heidelberg en_US
dc.relation.ispartof Rheumatology International
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Anxiety en_US
dc.subject Arthritis en_US
dc.subject Psoriatic en_US
dc.subject Depression en_US
dc.subject Rheumatic diseases en_US
dc.subject Quality of life en_US
dc.title Beyond expectations: disease duration and psychological burden in psoriatic arthritis en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id Yurdakul, Ozan Volkan/0000-0003-4567-8133
gdc.author.id Nas, Kemal/0000-0002-5845-0851
gdc.author.id Acer Kasman, Sevtap/0000-0002-4805-0555
gdc.author.id Orhan, Kevser/0000-0001-8639-751X
gdc.author.id Ecesoy, Hilal/0000-0001-9274-168X
gdc.author.id Kilic, Gamze/0000-0003-1998-0988
gdc.author.id alkan, hakan/0000-0001-8461-9131
gdc.author.scopusid 55540596500
gdc.author.scopusid 55531828900
gdc.author.scopusid 56244744500
gdc.author.scopusid 57022048500
gdc.author.scopusid 57192415206
gdc.author.scopusid 58475504100
gdc.author.scopusid 6603914253
gdc.author.wosid Yurdakul, Ozan Volkan/F-5266-2019
gdc.author.wosid Küçükakkaş, Okan/AAQ-2605-2020
gdc.author.wosid Sargın, Betül/JAC-0507-2023
gdc.author.wosid Nas, Kemal/HSG-2378-2023
gdc.author.wosid Acer Kasman, Sevtap/GLS-5561-2022
gdc.author.wosid Tekeoglu, Ibrahim/HTO-8999-2023
gdc.author.wosid KAMANLI, AYHAN/AAC-9523-2022
gdc.bip.impulseclass C4
gdc.bip.influenceclass C5
gdc.bip.popularityclass C4
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.description.department Atılım University en_US
gdc.description.departmenttemp [Kilic, Gamze; Capkin, Erhan] Karadeniz Tech Univ, Dept PMR, Div Rheumatol, Sch Med, Trabzon, Turkiye; [Kilic, Erkan] Kanuni Training & Res Hosp, Rheumatol Clin, Trabzon, Turkiye; [Tekeoglu, Ibrahim; Baykul, Merve; Kamanli, Ayhan; Nas, Kemal] Sakarya Univ, Dept PMR, Div Rheumatol & Immunol, Sch Med, Sakarya, Turkiye; [Sargin, Betul] Adnan Menderes Univ, Dept PMR, Div Rheumatol, Sch Med, Aydin, Turkiye; [Cengiz, Gizem; Calis, Mustafa] Erciyes Univ, Dept PMR, Div Rheumatol, Sch Med, Kayseri, Turkiye; [Balta, Nihan Cuzdan] Hatay Mustafa Kemal Univ, Dept PMR, Div Rheumatol, Sch Med, Hatay, Turkiye; [Alkan, Hakan] Pamukkale Univ, Dept PMR, Sch Med, Denizli, Turkiye; [Kasman, Sevtap Acer; Duruoz, Mehmet Tuncay] Marmara Univ, Dept PMR, Div Rheumatol, Sch Med, Istanbul, Turkiye; [Sahin, Nilay] Balikesir Univ, Dept PMR, Sch Med, Balikesir, Turkiye; [Orhan, Kevser] Ankara Bilkent City Hosp, Rheumatol Clin, Ankara, Turkiye; [Gezer, Ilknur Albayrak] Selcuk Univ, Dept PMR, Sch Med, Konya, Turkiye; [Keskin, Dilek] Kirikkale Univ, Dept PMR, Sch Med, Kirikkale, Turkiye; [Mulkoglu, Cevriye] Hlth Sci Univ, Ankara Training & Res Hosp, Dept PMR, Ankara, Turkiye; [Resorlu, Hatice] Canakkale Onsekiz Mart Univ, Dept PMR, Sch Med, Canakkale, Turkiye; [Ataman, Sebnem] Ankara Univ, Dept PMR, Div Rheumatol, Sch Med, Ankara, Turkiye; [Bal, Ajda] Univ Hlth Sci, Diskapi Yildirim Beyazit Training & Res Hosp, Dept PMR, Ankara, Turkiye; [Kucukakkas, Okan; Yurdakul, Ozan Volkan; Keskin, Yasar] Bezmialem Fdn Univ, Dept PMR, Istanbul, Turkiye; [Sen, Nesrin] Kartal Dr Lutfi Kirdar Training & Res Hosp, Dept Rheumatol, Kartal Dr, Istanbul, Turkiye; [Toprak, Murat] Yuzuncu Yil Univ, Dept PMR, Sch Med, Van, Turkiye; [Melikoglu, Meltem Alkan] Ataturk Univ, Dept PMR, Div Rheumatol, Sch Med, Erzurum, Turkiye; [Ayhan, Fikriye Figen] Atilim Univ, Dept PMR, Sch Med, Ankara, Turkiye; [Bodur, Hatice] Yildirim Beyazit Univ, Dept PMR, Sch Med, Ankara, Turkiye; [Devrimsel, Gul] Recep Tayyip Erdogan Univ, Dept PMR, Sch Med, Rize, Turkiye; [Hizmetli, Sami] Cumhuriyet Univ, Dept PMR, Div Rheumatol, Sch Med, Sivas, Turkiye; [Ecesoy, Hilal] Karamanoglu Mehmetbey Univ, Dept PMR, Div Rheumatol, Karaman, Turkiye; [Kutluk, Oznur; Tuncer, Tiraje] Akdeniz Univ, Dept PMR, Div Rheumatol, Sch Med, Antalya, Turkiye; [Sendur, Omer Faruk] Medicana Int Izmir Hosp, Dept PMR, Izmir, Turkiye; [Tolu, Sena] Medipol Univ, Dept PMR, Sch Med, Istanbul, Turkiye en_US
gdc.description.endpage 1704
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.startpage 1695
gdc.description.volume 43
gdc.description.wosquality Q2
gdc.identifier.openalex W4383480614
gdc.identifier.pmid 37418001
gdc.identifier.wos WOS:001024953900001
gdc.oaire.diamondjournal false
gdc.oaire.impulse 8.0
gdc.oaire.influence 2.8374225E-9
gdc.oaire.isgreen true
gdc.oaire.keywords Male
gdc.oaire.keywords Psoriatic Arthritis Quality of Life
gdc.oaire.keywords cost of illness
gdc.oaire.keywords clinical outcome
gdc.oaire.keywords Psoriatic
gdc.oaire.keywords Anxiety
gdc.oaire.keywords high risk patient
gdc.oaire.keywords Severity of Illness Index
gdc.oaire.keywords mental disease
gdc.oaire.keywords disease burden
gdc.oaire.keywords Rheumatic diseases
gdc.oaire.keywords Psoriasis Area and Severity Index
gdc.oaire.keywords Cost of Illness
gdc.oaire.keywords Surveys and Questionnaires
gdc.oaire.keywords disease modifying antirheumatic drug
gdc.oaire.keywords gender
gdc.oaire.keywords Health Assessment Questionnaire
gdc.oaire.keywords anxiety disorder
gdc.oaire.keywords comparative study
gdc.oaire.keywords psoriatic arthritis
gdc.oaire.keywords musculoskeletal disease assessment
gdc.oaire.keywords conventional synthetic disease modifying antirheumatic drug
gdc.oaire.keywords Depression
gdc.oaire.keywords adult
gdc.oaire.keywords disease course
gdc.oaire.keywords Fibromyalgia Rapid Screening Tool
gdc.oaire.keywords unclassified drug
gdc.oaire.keywords female
gdc.oaire.keywords Anxiety; Arthritis; Psoriatic; Depression; Rheumatic diseases; Quality of life
gdc.oaire.keywords retirement
gdc.oaire.keywords risk factor
gdc.oaire.keywords biological disease modifying antirheumatic drug
gdc.oaire.keywords biological therapy
gdc.oaire.keywords laboratory test
gdc.oaire.keywords depression
gdc.oaire.keywords Female
gdc.oaire.keywords biological product
gdc.oaire.keywords Quality of life
gdc.oaire.keywords unemployment
gdc.oaire.keywords quality of life assessment
gdc.oaire.keywords distress syndrome
gdc.oaire.keywords 610
gdc.oaire.keywords psychology
gdc.oaire.keywords patient-reported outcome
gdc.oaire.keywords Article
gdc.oaire.keywords male
gdc.oaire.keywords motivation
gdc.oaire.keywords Rheumatic Diseases
gdc.oaire.keywords physical disability
gdc.oaire.keywords cross-sectional study
gdc.oaire.keywords severity of illness index
gdc.oaire.keywords Humans
gdc.oaire.keywords human
gdc.oaire.keywords sociodemographics
gdc.oaire.keywords Motivation
gdc.oaire.keywords Arthritis
gdc.oaire.keywords enthesitis
gdc.oaire.keywords questionnaire
gdc.oaire.keywords disease association
gdc.oaire.keywords Arthritis, Psoriatic
gdc.oaire.keywords clinical assessment
gdc.oaire.keywords staging
gdc.oaire.keywords major clinical study
gdc.oaire.keywords quality of life
gdc.oaire.keywords Classification Criteria for Psoriatic Arthritis
gdc.oaire.keywords Quality of Life
gdc.oaire.keywords observational study
gdc.oaire.keywords disease duration
gdc.oaire.keywords disease activity
gdc.oaire.popularity 8.541233E-9
gdc.oaire.publicfunded false
gdc.openalex.fwci 2.854
gdc.openalex.normalizedpercentile 0.79
gdc.opencitations.count 7
gdc.plumx.mendeley 18
gdc.plumx.pubmedcites 5
gdc.plumx.scopuscites 7
gdc.scopus.citedcount 7
gdc.wos.citedcount 9
relation.isOrgUnitOfPublication 50be38c5-40c4-4d5f-b8e6-463e9514c6dd
relation.isOrgUnitOfPublication.latestForDiscovery 50be38c5-40c4-4d5f-b8e6-463e9514c6dd

Files

Collections